✦ LIBER ✦

A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated® human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease

✍ Scribed by Ari Zimran; Kenneth Loveday; Candida Fratazzi; Deborah Elstein

Book ID: 116304377
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 142 KB
Volume: 39
Category: Article
ISSN: 1079-9796
DOI: 10.1016/j.bcmd.2007.02.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

22 24-months on treatment: Open-label ph

22 24-months on treatment: Open-label phase I/II long-term study of enzyme replacement therapy (ERT) with Gene-Activated® human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease

✍ Ari Zimran; G. Altarescu; C. Fratazzi; R. Mensah; D. Elstein 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

118. 36 months on treatment: Open-label

118. 36 months on treatment: Open-label phase I/II long-term study of enzyme replacement therapy (ERT) with “gene-activated” human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease

✍ Ari Zimran; Kiran Bhirangi; Robert Mensah; Gheona Altarescu; Deborah Elstein 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Enzyme replacement therapy in a patient

Enzyme replacement therapy in a patient with type III Gaucher disease: Report of a paradigmatic case

✍ Vairo, Filippo; Dorneles, Alicia; Mittelstadt, Suzana; Wilke, Matheus; Doneda, D 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 110 KB

The effect of enzyme replacement therapy

The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease

✍ J Charrow; B Dulisse; GA Grabowski; NJ Weinreb 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Outcome of enzyme replacement therapy in

Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience

✍ P. Grigorescu Sido; C. Drugan; V. Cret; C. Al-Kzouz; C. Denes; C. Coldea; A. Zim 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 299 KB

Acute lymphoblastic leukemia in a patien

Acute lymphoblastic leukemia in a patient with type 1 Gaucher disease developing 1 year after discontinuation of enzyme replacement therapy

✍ Aditi Ranade; Sorin Selegean; Gagangeet Sandhu; Violette Ghali; Vijay P. Shah 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Higher rates of venous thromboembolism for Black-Americans are likely due to lower serum ## 25-hydroxyvitamin D levels To the editor: The recent paper on disparities of thromboembolism in the United States concluded that heritability may be important in the etiology of venous thromboembolism amon